SNY acquires KDMN for $9.50/sh cash—a 79% premium to yesterday’s close: https://www.globenewswire.com/news-release/2021/09/08/2293017/0/en/Sanofi-to-acquire-Kadmon-to-further-strengthen-growth-of-transplant-business.html The nominal deal value is $1.9B.